AZO
48
-2
EMR
51
-2
DAL
66
-2
LB
55
7
HPQ
37
6
FLR
30
-2
ADT
55
5
MDLZ
34
4
IR
35
-3
FSLR
49
-3
ABT
30
-3
GLW
82
3
NAVI
40
2
FFIV
52
3
MLM
50
2
XYL
33
-2
RSG
54
4
AMG
57
-3
NWL
39
-2
VTR
63
6
AZO
48
-2
EMR
51
-2
DAL
66
-2
LB
55
7
HPQ
37
6
FLR
30
-2
ADT
55
5
MDLZ
34
4
IR
35
-3
FSLR
49
-3
ABT
30
-3
GLW
82
3
NAVI
40
2
FFIV
52
3
MLM
50
2
XYL
33
-2
RSG
54
4
AMG
57
-3
NWL
39
-2
VTR
63
6
Financhill
Back

Astellas Pharma, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60

ALPMY
Astellas Pharma, Inc.

Last Price:
$16.48
Seasonality Move:
3.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Astellas Pharma, Inc. Stock Forecast

  • Over the next 52 weeks, Astellas Pharma, Inc. has on average historically risen by 6.7% based on the past 17 years of stock performance.
  • Astellas Pharma, Inc. has risen higher in 10 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
  • Is Astellas Pharma, Inc. Stock Undervalued?
    The current Astellas Pharma, Inc. [ALPMY] share price is $16.48. The Score for ALPMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALPMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Astellas Pharma, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Astellas Pharma, Inc. has on average historically risen by 6.7% based on the past 17 years of stock performance.

Astellas Pharma, Inc. Stock Rating

Buy
60
Astellas Pharma, Inc. (ALPMY) is a Buy

Is Astellas Pharma, Inc. overpriced?

  • Astellas Pharma, Inc. has risen higher in 10 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%

Astellas Pharma, Inc. Stock Price History

Is ALPMY stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Japan
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
astellas.com

52-Week Data

52-Week High:
17.35
52-Week Low:
8.37

Prediction Charts

Market Cap:
29B
Price in USD:
16.48
Volume:
81.8K
Beta:
0.43

Technical Analysis

SMA50:
15.42
SMA100:
14.26
SMA200:
12.43
52-Wk Change:
76.45%

Stock Predictions

  • Is Astellas Pharma, Inc. stock public?
    Yes, Astellas Pharma, Inc. is a publicly traded company.
  • What is the Astellas Pharma, Inc. stock quote today?
    The Astellas Pharma, Inc. stock price is 16.48 USD today.
  • How to buy Astellas Pharma, Inc. stock online?
    You can buy Astellas Pharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-16 14.38 14.88 14.88 14.38
Mar-17 14.88 15.15 15.18 14.85
Mar-18 15.42 15.07 15.87 15.03
Mar-19 15.00 14.99 15.54 14.83
Mar-20 15.43 14.61 15.43 14.61
Mar-23 15.00 15.21 15.90 15.00
Mar-24 15.59 15.73 16.12 15.59
Mar-25 15.36 15.99 16.00 15.36
Mar-26 15.96 15.78 15.96 15.71
Mar-27 16.07 16.09 16.30 15.92
Mar-30 17.35 16.14 17.35 16.11
Mar-31 16.09 16.22 16.50 15.86
Apr-1 16.50 16.78 16.89 16.50
Apr-2 16.24 16.48 16.56 16.20

Astellas Pharma, Inc. Earnings

Data Unavailable

Astellas Pharma, Inc. Forecast Revenue Growth

Data Unavailable

* Astellas Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.